Browsing by Author "Stein R.T."

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Severe chronic allergic (and related) diseases: A uniform approach - A MeDALL - GA2 LEN - ARIA position paper
    (2012) Bousquet J.; Anto J.M.; Demoly P.; Schünemann H.J.; Togias A.; Akdis M.; Auffray C.; Bachert C.; Bieber T.; Bousquet P.J.; Carlsen K.H.; Casale T.B.; Cruz A.A.; Keil T.; Lodrup Carlsen K.C.; Maurer M.; Ohta K.; Papadopoulos N.G.; Roman Rodriguez M.; Samolinski B.; Agache I.; Andrianarisoa A.; Ang C.S.; Annesi-Maesano I.; Ballester F.; Baena-Cagnani C.E.; Basagaña X.; Bateman E.D.; Bel E.H.; Bedbrook A.; Beghé B.; Beji M.; Ben Kheder A.; Benet M.; Bennoor K.S.; Bergmann K.C.; Berrissoul F.; Bindslev Jensen C.; Bleecker E.R.; Bonini S.; Boner A.L.; Boulet L.P.; Brightling C.E.; Brozek J.L.; Bush A.; Busse W.W.; Camargos P.A.M.; Canonica G.W.; Carr W.; Cesario A.; Chen Y.Z.; Chiriac A.M.; Costa D.J.; Cox L.; Custovic A.; Dahl R.; Darsow U.; Didi T.; Dolen W.K.; Douagui H.; Dubakiene R.; El-Meziane A.; Fonseca J.A.; Fokkens W.J.; Fthenou E.; Gamkrelidze A.; Garcia-Aymerich J.; Van Wijk R.G.; Gimeno-Santos E.; Guerra S.; Haahtela T.; Haddad H.; Hellings P.W.; Hellquist-Dahl B.; Hohmann C.; Howarth P.; Hourihane J.O.; Humbert M.; Jacquemin B.; Just J.; Kalayci O.; Kaliner M.A.; Kauffmann F.; Kerkhof M.; Khayat G.; Koffi N'Goran B.; Kogevinas M.; Koppelman G.H.; Kowalski M.L.; Kull I.; Kuna P.; Larenas D.; Lavi I.; Le L.T.; Lieberman P.; Lipworth B.; Mahboub B.; Makela M.J.; Martin F.; Martinez F.D.; Marshall G.D.; Mazon A.; Melen E.; Meltzer E.O.; Mihaltan F.; Mohammad Y.; Mohammadi A.; Momas I.; Morais-Almeida M.; Mullol J.; Muraro A.; Naclerio R.; Nafti S.; Namazova-Baranova L.; Nawijn M.C.; Nyembue T.D.; Oddie S.; O'Hehir R.E.; Okamoto Y.; Orru M.P.; Ozdemir C.; Ouedraogo G.S.; Palkonen S.; Panzner P.; Passalacqua G.; Pawankar R.; Pigearias B.; Pin I.; Pinart M.; Pison C.; Popov T.A.; Porta D.; Postma D.S.; Price D.; Rabe K.F.; Ratomaharo J.; Reitamo S.; Rezagui D.; Ring J.; Roberts R.; Roca J.; Rogala B.; Romano A.; Rosado-Pinto J.; Ryan D.; Sanchez-Borges M.; Scadding G.K.; Sheikh A.; Simons F.E.R.; Siroux V.; Schmid-Grendelmeier P.D.; Smit H.A.; Sooronbaev T.; Stein R.T.; Sterk P.J.; Sunyer J.; Terreehorst I.; Toskala E.; Tremblay Y.; Valenta R.; Valeyre D.; Vandenplas O.; Van Weel C.; Vassilaki M.; Varraso R.; Viegi G.; Wang D.Y.; Wickman M.; Williams D.; Wöhrl S.; Wright J.; Yorgancioglu A.; Yusuf O.M.; Zar H.J.; Zernotti M.E.; Zidarn M.; Zhong N.; Zuberbier T.
    Concepts of disease severity, activity, control and responsiveness to treatment are linked but different. Severity refers to the loss of function of the organs induced by the disease process or to the occurrence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases (rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in order to have a uniform definition of severity, control and risk, usable in most situations. It is based on the appropriate diagnosis, availability and accessibility of treatments, treatment responsiveness and associated factors such as comorbidities and risk factors. This uniform definition will allow a better definition of the phenotypes of severe allergic (and related) diseases for clinical practice, research (including epidemiology), public health purposes, education and the discovery of novel therapies. Copyright © 2012 S. Karger AG, Basel.
  • No Thumbnail Available
    Item
    Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
    (2012) Bousquet J.; Schünemann H.J.; Samolinski B.; Demoly P.; Baena-Cagnani C.E.; Bachert C.; Bonini S.; Boulet L.P.; Bousquet P.J.; Brozek J.L.; Canonica G.W.; Casale T.B.; Cruz A.A.; Fokkens W.J.; Fonseca J.A.; Van Wijk R.G.; Grouse L.; Haahtela T.; Khaltaev N.; Kuna P.; Lockey R.F.; Lodrup Carlsen K.C.; Mullol J.; Naclerio R.; O'hehir R.E.; Ohta K.; Palkonen S.; Papadopoulos N.G.; Passalacqua G.; Pawankar R.; Price D.; Ryan D.; Simons F.E.R.; Togias A.; Williams D.; Yorgancioglu A.; Yusuf O.M.; Aberer W.; Adachi M.; Agache I.; Aït-Khaled N.; Akdis C.A.; Andrianarisoa A.; Annesi-Maesano I.; Ansotegui I.J.; Baiardini I.; Bateman E.D.; Bedbrook A.; Beghé B.; Beji M.; Bel E.H.; Ben Kheder A.; Bennoor K.S.; Bergmann K.C.; Berrissoul F.; Bieber T.; Bindslev Jensen C.; Blaiss M.S.; Boner A.L.; Bouchard J.; Braido F.; Brightling C.E.; Bush A.; Caballero F.; Calderon M.A.; Calvo M.A.; Camargos P.A.M.; Caraballo L.R.; Carlsen K.H.; Carr W.; Cepeda A.M.; Cesario A.; Chavannes N.H.; Chen Y.Z.; Chiriac A.M.; Chivato Pérez T.; Chkhartishvili E.; Ciprandi G.; Costa D.J.; Cox L.; Custovic A.; Dahl R.; Darsow U.; De Blay F.; Deleanu D.; Denburg J.A.; Devillier P.; Didi T.; Dokic D.; Dolen W.K.; Douagui H.; Dubakiene R.; Durham S.R.; Dykewicz M.S.; El-Gamal Y.; El-Meziane A.; Emuzyte R.; Fiocchi A.; Fletcher M.; Fukuda T.; Gamkrelidze A.; Gereda J.E.; González Diaz S.; Gotua M.; Guzmán M.A.; Hellings P.W.; Hellquist-Dahl B.; Horak F.; Hourihane J.O'B.; Howarth P.; Humbert M.; Ivancevich J.C.; Jackson C.; Just J.; Kalayci O.; Kaliner M.A.; Kalyoncu A.F.; Keil T.; Keith P.K.; Khayat G.; Kim Y.Y.; Koffi N'Goran B.; Koppelman G.H.; Kowalski M.L.; Kull I.; Kvedariene V.; Larenas-Linnemann D.; Le L.T.; Lemière C.; Li J.; Lieberman P.; Lipworth B.; Mahboub B.; Makela M.J.; Martin F.; Marshall G.D.; Martinez F.D.; Masjedi M.R.; Maurer M.; Mavale-Manuel S.; Mazon A.; Melen E.; Meltzer E.O.; Mendez N.H.; Merk H.; Mihaltan F.; Mohammad Y.; Morais-Almeida M.; Muraro A.; Nafti S.; Namazova-Baranova L.; Nekam K.; Neou A.; Niggemann B.; Nizankowska-Mogilnicka E.; Nyembue T.D.; Okamoto Y.; Okubo K.; Orru M.P.; Ouedraogo S.; Ozdemir C.; Panzner P.; Pali-Schöll I.; Park H.S.; Pigearias B.; Pohl W.; Popov T.A.; Postma D.S.; Potter P.; Rabe K.F.; Ratomaharo J.; Reitamo S.; Ring J.; Roberts R.; Rogala B.; Romano A.; Roman Rodriguez M.; Rosado-Pinto J.; Rosenwasser L.; Rottem M.; Sanchez-Borges M.; Scadding G.K.; Schmid-Grendelmeier P.; Sheikh A.; Sisul J.C.; Solé D.; Sooronbaev T.; Spicak V.; Spranger O.; Stein R.T.; Stoloff S.W.; Sunyer J.; Szczeklik A.; Todo-Bom A.; Toskala E.; Tremblay Y.; Valenta R.; Valero A.L.; Valeyre D.; Valiulis A.; Valovirta E.; Van Cauwenberge P.; Vandenplas O.; Van Weel C.; Vichyanond P.; Viegi G.; Wang D.Y.; Wickman M.; Wöhrl S.; Wright J.; Yawn B.P.; Yiallouros P.K.; Zar H.J.; Zernotti M.E.; Zhong N.; Zidarn M.; Zuberbier T.; Ang C.S.; Baigenzhin A.K.; Boakye D.A.; Briggs A.H.; Burney P.G.; Busse W.W.; Chuchalin A.G.; Haddad H.; Johnston S.L.; Kogevinas M.; Levy M.L.; Mohammadi A.; Oddie S.; Rezagui D.; Terreehorst I.; Warner J.O.
    Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified AR as mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, and other health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. ARIA is disseminated and implemented in more than 50 countries of the world. Ten years after the publication of the ARIA World Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children. © 2012 American Academy of Allergy, Asthma & Immunology.
  • No Thumbnail Available
    Item
    Brief report: International perspectives on the pediatric COVID-19 experience
    (John Wiley and Sons Inc., 2020) Yilmaz O.; Gochicoa-Rangel L.; Blau H.; Epaud R.; Lands L.C.; Lombardi E.; Moore P.E.; Stein R.T.; Wong G.W.K.; Zar H.J.
    The 2019 novel coronavirus (SARS-CoV-2) is endangering human health worldwide; scarcity of published pediatric cases and current literature and the absence of evidence-based guidelines necessitate international sharing of experience and personal communication. On 31 March 2020 the International Committee of the American Thoracic Society Pediatrics Assembly recorded an online podcast, during which pediatric pulmonologists worldwide shared their experience on the novel coronavirus disease (COVID-19) in children. The aim was to share personal experience in organizing pediatric care in different health care settings globally, protecting health care workers, and isolation practices. This manuscript summarizes the common themes of the podcast which centered around three main topics: more benign clinical disease and progression in pediatric cases compared to adults, a strong need for strategies to protect health care workers, and social or economic disparities as a barrier to successful pandemic control. © 2020 Wiley Periodicals, Inc.